Literature DB >> 19067419

Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol.

Yukio Kato1, Tatsuya Miyazaki, Takashi Kano, Tomoko Sugiura, Yoshiyuki Kubo, Akira Tsuji.   

Abstract

Gastrointestinal absorption of several beta-blockers is inhibited by citrus juices, although molecular mechanism(s) lying on their small intestinal absorption has not yet been identified. Here, we attempted to demonstrate involvement of both influx and efflux transporters in vivo in gastrointestinal absorption of celiprolol in mice. Plasma concentration of celiprolol (3 mg/kg) after oral administration was mostly under the limit of quantification in wild mice, whereas that in mdr1a/b knockout (mdr1a/b(-/-)) mice was much more obvious, indicating P-glycoprotein-mediated efflux. Then, the oral absorption of celiprolol in mdr1a/b(-/-) mice was further examined to investigate influx transport mechanism with avoiding effect of P-glycoprotein. Coadministration of bromosulfophthalein (BSP), an inhibitor of various influx transporters including organic anion transporting polypeptide (OATP) reduced plasma celiprolol concentration. Inhibition by BSP of celiprolol uptake from apical membranes was confirmed in Ussing-type chamber of small intestinal tissues. Uptake of celiprolol by human small intestinal transporter OATP-A/1A2 was also confirmed in Xenopus Laevis oocytes. Interestingly, OATP-A/1A2 accepts various beta-blockers including acebutolol, atenolol and sotalol, oral absorption of which is inhibited by coadministration of citrus juice or telithromycin in human. Taken together, these findings have suggested fundamental role of influx transport system(s) in oral absorption of celiprolol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19067419     DOI: 10.1002/jps.21618

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

Review 1.  OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies.

Authors:  Megan Roth; Amanda Obaidat; Bruno Hagenbuch
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Influence of dietary substances on intestinal drug metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Curr Drug Metab       Date:  2010-11       Impact factor: 3.731

Review 3.  Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

Authors:  David G Bailey
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

4.  Dynamic analysis of GI absorption and hepatic distribution processes of telmisartan in rats using positron emission tomography.

Authors:  Makoto Kataoka; Tadayuki Takashima; Tomotaka Shingaki; Yoshinobu Hashidzume; Yumiko Katayama; Yasuhiro Wada; Hiroyuki Oh; Yoshie Masaoka; Shinji Sakuma; Yuichi Sugiyama; Shinji Yamashita; Yasuyoshi Watanabe
Journal:  Pharm Res       Date:  2012-05-23       Impact factor: 4.200

Review 5.  The role of transporters in the pharmacokinetics of orally administered drugs.

Authors:  Sarah Shugarts; Leslie Z Benet
Journal:  Pharm Res       Date:  2009-06-30       Impact factor: 4.200

6.  Orange and apple juice greatly reduce the plasma concentrations of the OATP2B1 substrate aliskiren.

Authors:  Tuija Tapaninen; Pertti J Neuvonen; Mikko Niemi
Journal:  Br J Clin Pharmacol       Date:  2011-05       Impact factor: 4.335

Review 7.  Renal Drug Transporters and Drug Interactions.

Authors:  Anton Ivanyuk; Françoise Livio; Jérôme Biollaz; Thierry Buclin
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

8.  Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum.

Authors:  Sara Eyal; Joong D Kim; Gail D Anderson; Megan L Buchanan; Debra A Brateng; Darcy Carr; David E Woodrum; Thomas R Easterling; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2010-02-09       Impact factor: 3.126

9.  Prediction of nonlinear intestinal absorption of CYP3A4 and P-glycoprotein substrates from their in vitro Km values.

Authors:  Tatsuhiko Tachibana; Motohiro Kato; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2011-09-13       Impact factor: 4.200

Review 10.  Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

Authors:  Christina S Won; Nicholas H Oberlies; Mary F Paine
Journal:  Pharmacol Ther       Date:  2012-08-04       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.